Daniel O. Stram

Daniel O. Stram

Auto-generated profile, based on publicly available information

Daniel O. Stram

Department of Preventive Medicine, Keck School of Medicine and Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California, United States of America

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2003 in Human Heredity
Verified
Journal Article
Closed access
PDF file
DSDaniel O. Stram
Daniel O. Stram
CHChristopher A. Haiman
Christopher A. Haiman
JHJoel N. Hirschhorn
Joel N. Hirschhorn
DADavid Altshuler
David Altshuler
LKLaurence N. Kolonel
Laurence N. Kolonel
MPMalcolm C. Pike
Malcolm C. Pike
We describe an approach for picking haplotype-tagging single nucleotide polymorphisms (htSNPs) that is presently being taken in two large nested case-control studies within a multiethnic cohort (MEC), which are engaged in a search for associations between risk of prostate and breast cancer and common genetic variations in candidate genes. Based on a preliminary sample of 70 control subjects chosen at random from each of the 5 ethnic groups in the MEC we estimate haplotype frequencies using a variant of the Excoffier-Slatkin E-M algorithm after genotyping a high density of SNPs selected every 3–5 kb in and surrounding a candidate gene. In order to evaluate the performance of a candidate set of htSNPS (which will be genotyped in the much larger case-control sample) we treat the haplotype frequencies estimate above as known, and carry out a formal calculation of the uncertainty of the number of copies of common haplotypes carried by an individual, summarizing this calculation as a coefficient of determination, R2h. A candidate set of htSNPS of a given size is chosen so as to maximize the minimum value of R2h over the common haplotypes, h.

1 October 2003 in Human Heredity
Verified
Journal Article
Closed access
PDF file
DSDaniel O. Stram
Daniel O. Stram
CPCeleste Leigh Pearce
Celeste Leigh Pearce
PBPhillip Bretsky
Phillip Bretsky
MFMatthew Freedman
Matthew Freedman
JHJoel N. Hirschhorn
Joel N. Hirschhorn
DTDuncan C. Thomas
Duncan C. Thomas
The US National Cancer Institute has recently sponsored the formation of a Cohort Consortium (http://2002.cancer.gov/scpgenes.htm) to facilitate the pooling of data on very large numbers of people, concerning the effects of genes and environment on cancer incidence. One likely goal of these efforts will be generate a large population-based case-control series for which a number of candidate genes will be investigated using SNP haplotype as well as genotype analysis. The goal of this paper is to outline the issues involved in choosing a method of estimating haplotype-specific risk estimates for such data that is technically appropriate and yet attractive to epidemiologists who are already comfortable with odds ratios and logistic regression. Our interest is to develop and evaluate extensions of methods, based on haplotype imputation, that have been recently described (Schaid et al., Am J Hum Genet, 2002, and Zaykin et al., Hum Hered, 2002) as providing score tests of the null hypothesis of no effect of SNP haplotypes upon risk, which may be used for more complex tasks, such as providing confidence intervals, and tests of equivalence of haplotype-specific risks in two or more separate populations. In order to do so we (1) develop a cohort approach towards odds ratio analysis by expanding the E-M algorithm to provide maximum likelihood estimates of haplotype-specific odds ratios as well as genotype frequencies; (2) show how to correct the cohort approach, to give essentially unbiased estimates for population-based or nested case-control studies by incorporating the probability of selection as a case or control into the likelihood, based on a simplified model of case and control selection, and (3) finally, in an example data set (CYP17 and breast cancer, from the Multiethnic Cohort Study) we compare likelihood-based confidence interval estimates from the two methods with each other, and with the use of the single-imputation approach of Zaykin et al. applied under both null and alternative hypotheses. We conclude that so long as haplotypes are well predicted by SNP genotypes (we use the R2h criteria of Stram et al. [1]) the differences between the three methods are very small and in particular that the single imputation method may be expected to work extremely well.

15 September 2004 in Genetic Epidemiology
Verified
Journal Article
Closed access
PDF file
DSDaniel O. Stram
Daniel O. Stram

8 December 2017 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
JFJane C Figueiredo
Jane C Figueiredo
CHChristopher Haiman
Christopher Haiman
JPJacqueline Porcel
Jacqueline Porcel
JBJames Buxbaum
James Buxbaum
DSDaniel Stram
Daniel Stram
VSVeronica Wendy Setiawan
Veronica Wendy Setiawan
Gallbladder disease (GBD) is a highly prevalent condition; however, little is known about potential differences in risk factors by sex and ethnicity/race. Our aim was to evaluate dietary, reproductive and obesity-related factors and GBD in multiethnic populations. We performed a prospective analysis from the Multiethnic Cohort study who self-identified as non-Hispanic White (n = 32,103), African American (n = 30,209), Japanese (n = 35,987), Native Hawaiian (n = 6942) and Latino (n = 39,168). GBD cases were identified using Medicare and California hospital discharge files (1993–2012) and self-completed questionnaires. We used exposure information on the baseline questionnaire to identify exposures of interest. Associations were estimated by hazard ratios and 95% confidence intervals using Cox models adjusted for confounders. After a median 10.7 years of follow-up, there were 13,437 GBD cases. BMI over 25 kg/m2, diabetes, past and current smoking, red meat consumption, saturated fat and cholesterol were significant risk factors across ethnic/racial populations (p-trends < 0.01). Protective factors included vigorous physical activity, alcohol use, fruits, vegetables and foods rich in dietary fiber (p-trends < 0.01). Carbohydrates were inversely associated with GBD risk only among women and Latinos born in South America/Mexico (p-trend < 0.003). Parity was a significant risk factor among women; post-menopausal hormones use was only associated with an increased risk among White women (estrogen-only: HR = 1.24; 95% CI = 1.07–1.43 and estrogen + progesterone: HR = 1.23; 95% CI = 1.06–1.42). Overall, dietary, reproductive and obesity-related factors are strong risk factors for GBD affecting men and women of different ethnicities/races; however some risk factors appear stronger in women and certain ethnic groups.

1 March 2019 in Gastroenterology
Verified
Journal Article
Closed access
PDF file
ULUnhee Lim
Unhee Lim
KMKristine R. Monroe
Kristine R. Monroe
SBSteve Buchthal
Steve Buchthal
BFBo Fan
Bo Fan
ICIona Cheng
Iona Cheng
LMLoïc Le Marchand
Loïc Le Marchand

10 April 2006 in Genetic Epidemiology
Verified
Journal Article
Closed access
PDF file
HWHansong Wang
Hansong Wang
DTDuncan C. Thomas
Duncan C. Thomas
IPItsik Pe'ER
Itsik Pe'ER
DSDaniel O. Stram
Daniel O. Stram